After having performed strongly through the week, the Therapeutic Solutions (OTCMKTS:TSOI) stock corrected sharply this past Friday and went down by 11%. However, in this regard, it is also necessary to keep in mind that the stock ended up clocking gains of 67% for the whole of previous week.
Last Friday the Chief Executive Officer of the company Timothy Dixon provided the details of the plans by way of which Therapeutic Solutions is going to finance the next stage of development of its product JadiCell. JadiCell, which is a COVID 19 therapy from being developed by the company, is one of the more ambitious projects at Therapeutic Solutions at this point.
The company’s CEO laid out his thoughts in a blog post that was published last Friday. Whenever a company looks into raising more cash there is always a fear among investors that the fund raising efforts might lead to dilutions of the stock.
However, Dixon stated in his blog post that dilution was not even in his mind and went on to state that the company was making efforts to get funding from the government. Although the stock declined last Friday, it might be a good time for investors to add the Therapeutic Solutions stock to their watch lists.
